Kintor Pharmaceutical (9939.HK) Earnings Analysis
Kintor Pharmaceutical (9939.HK) next reports earnings on 2026-08-31. Trailing P/E -3.35.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 9939.HK next report earnings?
| Next earnings date | 2026-08-31 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
9939.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-08-26 | -0.18265 HKD | n/a | n/a | n/a |
9939.HK valuation and analyst view
| Trailing P/E | -3.35 |
|---|---|
| Trailing EPS | -0.42558 HKD |
| Price / book | 3.73 |
| Dividend yield | 0.00% |
| Market cap | 0.80B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Kintor Pharmaceutical (9939.HK)'s next earnings date?
Kintor Pharmaceutical is next scheduled to report on 2026-08-31.
Did 9939.HK beat earnings last quarter?
Consensus estimate data was not available for 9939.HK's 2024-08-26 report.
What is 9939.HK's current P/E ratio and EPS?
9939.HK trades at a trailing P/E of -3.35 on trailing EPS of -0.42557871524455976 HKD.
What do analysts rate 9939.HK?
9939.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.